Key Takeaways
- • China's venture capital funding contracted 21.7% to $35.2 billion in 2024, representing a significant decline from the prior year despite signs of stabilization in transaction volume.
- • The number of venture capital investment transactions rebounded to 7,078 in 2024, marking a 6.9% year-over-year increase, suggesting renewed deal activity even as capital deployment weakened.
- • Corporate venture capital (CVC) fund registrations fell sharply to 193 new funds in 2024, down 41.7% compared to 2023, indicating structural pullback among strategic corporate investors.
- • Total investment amount across China's broader venture ecosystem remained stable at approximately 824.982 billion yuan in 2024, demonstrating resilience in domestic capital allocation despite international headwinds.
- • China's VC market underperformed regional peers, with Asia-Pacific venture capital reaching a nine-year low of $78.8 billion, positioning China's contraction within a broader regional deceleration.
Summary
The contraction in corporate venture capital proved particularly acute. Newly registered CVC funds dropped to 193 in 2024, marking a 41.7% decline from 2023 levels and reaching a decade-low, according to the 2024 Chinese Corporate Venture Capital Development Report. This pullback among strategic corporate investors suggests reduced appetite from established enterprises to fund early-stage innovation, potentially limiting capital availability for seed and Series A funding rounds.
Total venture investment volume within China's broader ecosystem remained stable at approximately 824.982 billion yuan, indicating that while international dollar-denominated funding faced headwinds, domestic RMB-denominated capital maintained its position. This stability points to ongoing state and domestic institutional support for the startup sector, even as global venture capital conditions tightened. The $35.2 billion figure for 2024 must be contextualized within a broader regional slowdown: Asia-Pacific venture capital fell to a nine-year low of $78.8 billion, with China traditionally accounting for roughly half of regional deal activity.
The mixed signals—declining dollar funding but rising transaction counts and stable RMB deployment—suggest China's venture market is rebalancing rather than collapsing. Institutional investors should monitor whether state-directed capital continues to support domestic innovation initiatives and whether the nascent recovery in deal volume translates into meaningful capital deployment in subsequent quarters.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.